美企业软件商MicroStrategy动用10亿美元增持比特币 总持货近45亿美元
美国企业软件商微策略(MicroStrategy)(MSTR.US)宣布,增持逾1.94万单位比特币,总值逾10亿美元,每单位比特币平均买入成本52,765美元,包括费用及其他支出。公司目前持有逾9万单位比特币,总值近45亿美元,平均买入价23,985美元,买入成本21.71亿美元。
公司去年8月首次披露持有比特币,利用手上现金结余购买,其後完成两次可换股债发行,集资购买比特币。其中第二次集资於上周进行,集资额10.3亿美元,债券票面息率为零。
微策略股价昨日(24日)升18.3%报817.69美元,今年以来股价已升九成。投资者买入该股以变相参与比特币热潮。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.